Team says research results show existing safe-in-human broad-spectrum antivirals could be used on other viral infections.
International research team says focus should now be on deprescribing to limit the potential harm associated with anticholinergic drugs.
Partners aim to develop preclinical Empowered Cytokines that target IL4R
A large Phase III trial, the Impassion130 trial, has produced results supporting the use of chemotherapy plus immunotherapy as first-line treatment in certain patients...
Active pharmaceutical ingredient from coralberry leaves might serve as a novel treatment for asthma
Rotavirus vaccination reduced infant diarrhea deaths by 34% in rural Malawi.
Deal signed less than a month before the planned launch of the opioid-induced constipation (OIC) treatment for adults with chronic non-cancer pain.
A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection.
Pergamum agreed to collaborate with Cadila Pharmaceuticals to develop a new treatment for infections based on a novel targeting mechanism that is different from classical antibiotic therapy.
Please wait while you are redirected to the right page...